Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Notice to Our Valued Users

Elsevier has made the difficult decision to close PracticeUpdate permanently. There will be no new content published, effective immediately. Although we are all disappointed by this news, we are incredibly grateful for your engagement and support over the years.

We thank the Editorial Boards, Advisory Boards, and Editorial Contributors for their many years of dedication to educating the healthcare community. Our appreciation extends to the many contributors who have shared their valuable time and expertise to help us parse the latest research over the years.

We encourage you to explore our other offerings such as ScienceDirect and ClinicalKey, which continue to provide valuable insights and information to help you excel in your practice.

If you have any questions or need assistance, please see the FAQs section or contact the support team. Thank you for being a part of the PracticeUpdate community!

Jonathan Temte MD, PhD Advisory Board

David Rakel MD, FAAFP Editor-in-Chief

Tricia C. Elliott MD, FAAFP Associate Editor

See All Experts

Published in Primary Care

Journal Scan / Research · February 24, 2024

Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease

JAMA Internal Medicine

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

Additional Info

Article Citation

JAMA Internal Medicine

Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease

JAMA Intern Med 2024 Feb 12;[EPub Ahead of Print], H Jang, Y Kim, DH Lee, SK Joo, BK Koo, S Lim, W Lee, W Kim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Notice to Our Valued Users

Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease

Additional Info

Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease

Further Reading

Final Note From the Primary Care Editors

Incident Stroke After First-Time Transient Ischemic Attack According to ABCD2 Score

Association of Antiobesity Medication Treatment With Alcohol Use

Light-to-Moderate Wine Consumption Tied to Lower Cardiovascular Disease Risk

Respiratory Benefits of Multisetting Air Purification in Children

Prophylaxis Options in Children With a History of Recurrent Urinary Tract Infections

Patient Hospitalized in Louisiana With First U.S. Case of Severe Bird Flu

Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder

Association of Children's Electronic Media Use With Physical Activity, Cognitive Function, and Stress

Association of Chocolate Intake With Risk of Type 2 Diabetes

Orthostatic and Standing Hypertension and Risk of Cardiovascular Disease

Recently Updated